Apotex Research Profile
Key Indicators
- Authorised Capital ₹ 460.00 Cr
as on 16-11-2024
- Paid Up Capital ₹ 291.86 Cr
as on 16-11-2024
- Company Age 21 Year, 6 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 483.80 Cr
as on 16-11-2024
- Revenue 16.63%
(FY 2023)
- Profit 109.79%
(FY 2023)
- Ebitda 24.96%
(FY 2023)
- Net Worth -0.42%
(FY 2023)
- Total Assets -4.46%
(FY 2023)
About Apotex Research
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 460.00 Cr and a paid-up capital of Rs 291.86 Cr.
The company currently has active open charges totaling ₹483.80 Cr.
The Key Managerial Personnel (KMP) at Apotex Research Private Limited India is Indrajyoti Bose as COMPANY SECRETARY. Yoganjaneya Panem, Goutam Pujari, Brian Mcclelland, and One other member serve as directors at the Company.
- CIN/LLPIN
U73100KA2003PTC032103
- Company No.
032103
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
16 Jun 2003
- Date of AGM
24 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Bangalore
Industry
Company Details
- LocationJigani Hobli, Karnataka
- Telephone
- Email Address
- Website
- Social Media
What products or services does Apotex Research Private Limited offer?
Apotex Research Private Limited offers a wide range of products and services, including Business Planning and Management, Business Consultant, Pain Relief Drugs & Pharmaceuticals, Arthritic Drugs.
Who are the key members and board of directors at Apotex Research?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Indrajyoti Bose | Company Secretary | 05-Aug-2016 | Current |
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Yoganjaneya Panem  | Director | 30-Nov-2018 | Current |
| Goutam Pujari | Director | 01-Dec-2018 | Current |
Brian Mcclelland  | Director | 20-Mar-2024 | Current |
| Kajal Palan | Additional Director | 08-Apr-2024 | Current |
Financial Performance and Corporate Structure Insights of Apotex Research.
Apotex Research Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 16.63% increase. The company also saw a substantial improvement in profitability, with a 109.79% increase in profit. The company's net worth dipped by a decrease of 0.42%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Apotex Research?
In 2023, Apotex Research had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Apotex Pharmachem India Private LimitedActive 21 years 6 monthsYoganjaneya Panem, Brian Mcclelland and 1 more are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 30 Sep 2023 | ₹30.00 Cr | Open |
Others Creation Date: 09 Jun 2017 | ₹5.00 Cr | Open |
The Hongkong And Shanghai Banking Corporation Limited Creation Date: 24 Mar 2016 | ₹8.00 M | Open |
How Many Employees Work at Apotex Research?
Apotex Research has a workforce of 1236 employees as of Apr 09, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Apotex Research, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Apotex Research's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
